Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.

Source:http://linkedlifedata.com/resource/pubmed/id/9392621

J. Natl. Cancer Inst. 1997 Dec 3 89 23 1797-802

Download in:

View as

Triples

General Info

PMID
9392621